Financing channel feed – Endpoints News

Financing channel feed

An EU biotech looks to rewrite the ugly history of phosphatases, and it's taking $24M in funding to get off the ground

5 years ago

On the hunt for bugs outside the gut, Seed Health snares $40M round to advance pipeline with the help of George Church

5 years ago

Peter Thiel-backed ATAI is preparing to go to Nasdaq, as interest in psychedelics reaches fever pitch

5 years ago

Versant pulls the wraps off of nearly $1B in 3 new funds out to build the next fleet of biotech startups. And this new generation is built for speed

5 years ago

RA Capital leads $125M for Janux in VC's latest crossover bid

5 years ago

Samantha Du's Zai Lab sets its ambitions sky high, looking to raise $750M to fuel its licensing business model

5 years ago

No AAV? No problem. Code Biotherapeutics joins the search for a non-viral gene therapy

5 years ago

Chen Yu jumps ship from Vivo Capital and goes large, allying with The Column Group on an inaugural $824M biotech crossover fund

5 years ago

Tillman Gerngross' Covid-19 antibody moonshot scores $336M with the help of new ace CFO. Is an IPO next?

5 years ago

Biotech's IPO raise approaches $5.5B as Nasdaq continues to prove fruitful with 2 debuts and three new filings

5 years ago

Osman Kibar lays down his hand at Samumed, stepping away from CEO role as his once-heralded anti-aging biotech rebrands

5 years ago

Alchemab bags fresh round of investors for target-agnostic antibody development for Huntington's, Covid-19

5 years ago

The world of Wnt heads to Nasdaq as Surrozen announces a $212M SPAC deal

5 years ago

After a major facelift, AltruBio says it's ready for a pivotal fight against graft-versus-host disease

5 years ago

With a new method to synthesize DNA, San Diego's Molecular Assemblies notches $24M Series A

5 years ago

Meet Benchling, the latest unicorn seeking to revolutionize the way scientists do work with the help of the cloud

5 years ago

It takes two to Tango: The biotech using CRISPR to discover new cancer gene targets rides a $353M SPAC deal to Nasdaq

5 years ago

Bain doubles down on Tony Coles’ quest to get a late-stage Parkinson’s drug through to market

5 years ago

Jaguar, Sean Nolan's latest biotech, raises $139M as they follow Taysha's footsteps

5 years ago

Toad venom to treat depression? RA Capital wagers $125M on latest psychedelic biotech

5 years ago

Arcellx raises mega-round to put controllable CAR-T into the clinic

5 years ago

OrbiMed-backed Theseus debuts with $100M round in heroic quest for 'pan-variant' kinase inhibitors

5 years ago

Investors throw $189M at Flagship startup's mission to 'decode' interactions between T cells and antigens

5 years ago

The hunt for a hep B cure heats up, as Antios Therapeutics preps for an IPO

5 years ago

First page Previous page 78 79 808182 83 84 Next page Last page